British Menopause Society
void void

BMS Consensus Statements: Summary & Practice Points

Title: Urogenital atrophy.

Urogenital atrophy
Joan Pitkin and Margaret Rees on behalf of the British Menopause Society Council
27 May 2008

Summary


The British Menopause Society Council aims to aid health professionals to inform and advise women about postreproductive health. This guidance refers to the long-term condition of urogenital atrophy. Treatment choice should be based on up to date information and targeted to individual women's needs. Non-estrogen and estrogen-based treatments are discussed.

Summary practice points

  • Urogenital atrophy is a common postreproductive health problem
  • Both non-estrogen and estrogen based treatments can be used
  • Low dose topical estradiol and estriol preparations used in the recommended doses do not need added progestogen
  • Treatment is long term and may be required for many years as symptoms return on its cessation

The full statement, scientific papers, charts, presentations etc are available in the members area. » Join here

« go back

 

            email^ back to top

Last updated: 20 May 2013
British Menopause Society 4-6 Eton Place, Marlow, Buckinghamshire. UK. SL7 2QA
Tel: + 44 (0) 1628 890199    Fax: + 44 (0) 1628 474042    Registered Charity no: 1015144
corner corner